EP2018866A1 — Pharmaceutical compositions containing voriconazole
Assigned to Sandoz AG · Expires 2009-01-28 · 17y expired
What this patent protects
The present invention provides a process for improving the solubility of voriconazole in aqueous solutions. The present invention also provides a composition comprising voriconazole and a beta-cyclodextrin obtainable by this process, a method of treating a fungal infection, a pha…
USPTO Abstract
The present invention provides a process for improving the solubility of voriconazole in aqueous solutions. The present invention also provides a composition comprising voriconazole and a beta-cyclodextrin obtainable by this process, a method of treating a fungal infection, a pharmaceutical composition comprising the composition comprising voriconazole and a beta-cyclodextrin and the use of a therapeutically effective amount of the composition comprising voriconazole and a beta-cyclodextrin and at least one pharmaceutically acceptable excipient for the preparation of a medicament for treating a fungal infection.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.